Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Jorgensen

Showing results (11-20 of 216) with videos related to

Pageof 22
Sort By:
Immunology Today|September 24, 1998
Gene therapy in osteoarticular diseases: where are we?C Jorgensen, S Gay
La Revue De Medecine Interne|December 31, 2002
[Treatment of rheumatoid arthritis by interleukin-1 receptor antagonist]D Wendling, C Jorgensen
La Revue Du Praticien|December 15, 1991
[Rheumatoid wrist]J Sany, C Jorgensen
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|March 1, 1993
Ultrasound screening during pregnancy: psychological strain experienced by the investigating staffI Ursing, C Jorgensen
Journal of Medicinal Chemistry|May 1, 1970
Thyroxine analogs. 18. 3,5-dialkyl-3'-halo-DL-thyronines and their 3'-methyl and 4'-amino analogsE C Jorgensen, J Wright
Human Genetics|January 1, 1989
H-Y antigenicity of human fibroblastsC Jorgensen, E J Eichwald
Journal of Medicinal Chemistry|July 1, 1970
Thyroxine analogs. XIX. 3,5-dimethyl-3'-isopropyl-DL-thyronineE C Jorgensen, J Wright
Human Genetics|April 1, 1989
Response to Wiberg's remarks on our article: "H-Y Antigenicity of Human Fibroblasts"C Jorgensen, E J Eichwald
Journal of Medicinal Chemistry|November 1, 1971
Thyroxine analogs. 20. Substituted 1- and 2-naphthyl ethers of 3,5-diiodotyrosineE C Jorgensen, P Slade
Transplantation|July 1, 1984
Cell-mediated hyperacute rejection. V. Cessation of transfer effectivenessE J Eichwald, C Jorgensen
Pageof 22

Showing results (11-20 of 216) with videos related to

Sort By:
Pageof 22
Immunology Today|September 24, 1998
Gene therapy in osteoarticular diseases: where are we?C Jorgensen, S Gay
La Revue De Medecine Interne|December 31, 2002
[Treatment of rheumatoid arthritis by interleukin-1 receptor antagonist]D Wendling, C Jorgensen
La Revue Du Praticien|December 15, 1991
[Rheumatoid wrist]J Sany, C Jorgensen
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|March 1, 1993
Ultrasound screening during pregnancy: psychological strain experienced by the investigating staffI Ursing, C Jorgensen
Journal of Medicinal Chemistry|May 1, 1970
Thyroxine analogs. 18. 3,5-dialkyl-3'-halo-DL-thyronines and their 3'-methyl and 4'-amino analogsE C Jorgensen, J Wright
Human Genetics|January 1, 1989
H-Y antigenicity of human fibroblastsC Jorgensen, E J Eichwald
Journal of Medicinal Chemistry|July 1, 1970
Thyroxine analogs. XIX. 3,5-dimethyl-3'-isopropyl-DL-thyronineE C Jorgensen, J Wright
Human Genetics|April 1, 1989
Response to Wiberg's remarks on our article: "H-Y Antigenicity of Human Fibroblasts"C Jorgensen, E J Eichwald
Journal of Medicinal Chemistry|November 1, 1971
Thyroxine analogs. 20. Substituted 1- and 2-naphthyl ethers of 3,5-diiodotyrosineE C Jorgensen, P Slade
Transplantation|July 1, 1984
Cell-mediated hyperacute rejection. V. Cessation of transfer effectivenessE J Eichwald, C Jorgensen
Pageof 22